“The big one.” “A major victory.” “A game changer.” That’s how many lawyers in the defense bar described Monday’s landmark decision by the U.S. Supreme Court in Bristol-Myers Squibb v. Superior Court of California.
They’re not too far off. In mere hours, a judge in Missouri ended a pivotal trial over Johnson & Johnson’s baby powder because of the court’s decision, granting a mistrial in a courtroom in St. Louis, a venue favored by many plaintiffs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
